Literature DB >> 16019771

Impact of finasteride treatment on perioperative bleeding before transurethral resection of the prostate: a prospective randomized study.

Lars Lund1, Klaus Møller Ernst-Jensen, Niels Tørring, Jens Erik Nielsen.   

Abstract

In this preliminary, randomized study, 35 men were pretreated for 3 months with finasteride or placebo before transurethral resection of the prostate. The study was inconclusive because it did not show any benefit in terms of reducing perioperative bleeding during or after the resection but there is a need for a large, prospective, randomized study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019771     DOI: 10.1080/00365590510007694

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  9 in total

1.  Impact of oral anticoagulation on morbidity of transurethral resection of the prostate.

Authors:  Aurélien Descazeaud; Gregoire Robert; Souhil Lebdai; Alain Bougault; Abdel Rahmene Azzousi; Olivier Haillot; Marian Devonec; Marc Fourmarier; Christian Saussine; Nicolas Barry-Delongchamps; Alexandre de la Taille
Journal:  World J Urol       Date:  2010-06-25       Impact factor: 4.226

Review 2.  A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.

Authors:  Huan-Tao Zong; Xiao-Xia Peng; Chen-Chen Yang; Yong Zhang
Journal:  Asian J Androl       Date:  2011-09-05       Impact factor: 3.285

3.  Effect of preoperative finasteride on perioperative blood loss during transurethral resection of the prostate and on microvessel density in patients with benign prostatic hyperplasia: An open label randomized controlled trial.

Authors:  Uma Kant Dutt; Sunil Kumar; Lalgudi Narayanan Dorairajan; Bhawana Ashok Badhe; Ramanitharan Manikandan; Suresh Singh
Journal:  Urol Ann       Date:  2021-07-14

4.  Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study.

Authors:  Cong Zhu; Lan Yang; Hao Zi; Bing-Hui Li; Qiao Huang; Meng-Xin Lu; Xiao-Dong Li; Xuan-Yi Ren; Hua Tao; Hankun Hu; Xian-Tao Zeng
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

Review 5.  Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?

Authors:  Matthew Bruha; Charles Welliver
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

Review 6.  Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.

Authors:  Yi-Ping Zhu; Bo Dai; Hai-Liang Zhang; Guo-hai Shi; Ding-Wei Ye
Journal:  BMC Urol       Date:  2015-06-02       Impact factor: 2.264

7.  Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate.

Authors:  Chi-Hang Yee; Joseph Hon-Ming Wong; Peter Ka-Fung Chiu; Jeremy Yuen-Chun Teoh; Chi-Kwok Chan; Eddie Shu-Yin Chan; See-Ming Hou; Chi-Fai Ng
Journal:  Urol Ann       Date:  2016 Oct-Dec

8.  Preoperative treatment with 5α-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate - A population-based cohort study.

Authors:  Ti-Yuan Yang; Marcelo Chen; Wun-Rong Lin; Chung-Yi Li; Wei-Kung Tsai; Allen W Chiu; Ming-Chung Ko
Journal:  Clinics (Sao Paulo)       Date:  2018-03-12       Impact factor: 2.365

9.  Current status of 5α-reductase inhibitors in prostate disease management.

Authors:  Dong Il Kang; Jae Il Chung
Journal:  Korean J Urol       Date:  2013-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.